Study: Traditional prostate cancer risks don’t predict hormone therapy benefit
A large analysis led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has challenged a widely used assumption ...
A large analysis led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has challenged a widely used assumption ...
In the evolving landscape of prostate cancer treatment, hormone-sensitive prostate cancer (HSPC) has traditionally been managed with androgen-deprivation therapy (ADT) ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine